The Effects of Proprioceptive Neuromuscular Facilitation

NCT07344272 | Recruiting

• 1 other identifier: CBU-FTR-ES-O7
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to investigate the effects of proprioceptive neuromuscular facilitation (PNF) on shoulder girdle function and quality of life in individuals with scapular winging.

Conditions

Scapular Winging

Keywords

Functional status; Neuromuscular effect; Proprioceptive neuromuscular facilitation; Quality of life; Scapula

Outcome Measures

Primary Outcomes (1)

• Biodex System 3 Pro

  Isokinetic strength measurement of the shoulder girdle muscles will be performed using a Biodex System 3 Pro isokinetic dynamometer. The measurements will be conducted in a diagonal plane specifically determined to align with scapular patterns, utilizing a concentric-concentric mode at two different angular velocities: 60°/s and 180°/s. For each test, participants will perform three trial sets; the peak torque values obtained from each set will be normalized to body weight (Nm/kg) and averaged for statistical analysis. During the test protocol, participants will be securely positioned using stabilization straps to ensure arm and trunk stability. Prior to the measurements, a device orientation and warm-up session (e.g., three practice/familiarization sets) will be conducted, followed by the actual data collection.

  one week

Secondary Outcomes (4)

• Scapular Isometric Pinch Test

  one week

• The Lateral Scapular Slide Test

  one week

• Disabilities of the Arm, Shoulder, and Hand Questionnaire

  one week

• Short Form-36

  one week

Study Arms (2)

Proprioceptive Neuromuscular Facilitation Group

ACTIVE COMPARATOR

The Proprioceptive Neuromuscular Facilitation Group will receive proprioceptive neuromuscular facilitation for a duration of 5 weeks, scheduled three times per week, with a session length of approximately 20-30 minutes.

Other: Proprioceptive neuromuscular facilitation

Control Group

NO INTERVENTION

The Control Group will receive no intervention.

Interventions

Proprioceptive neuromuscular facilitation OTHER

The Proprioceptive Neuromuscular Facilitation Group will receive proprioceptive neuromuscular facilitation for a duration of 5 weeks, scheduled three times per week, with a session length of approximately 20-30 minutes.

Proprioceptive Neuromuscular Facilitation Group

Eligibility Criteria

• Age: 20 Years - 40 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Volunteering to participate in the study.
• Presenting with bilateral scapular winging (Scapular winging will be evaluated by measuring the distance between the inferior angle of the scapula and the thoracic wall using a scapulometer; a distance of ≥2 cm is considered as winging).

You may not qualify if:

• Presence of long thoracic nerve palsy.
• Having undergone shoulder surgery within the last 12 months or having an acute shoulder injury (e.g., rotator cuff tear, dislocation, labral pathology, etc.).
• Presence of scapulothoracic bursitis, fractures, tumors, or structural deformities in the scapular/thoracic region.
• Having received regular scapular or shoulder rehabilitation within the last 6 months.

Sponsors & Collaborators

• Celal Bayar University: lead

Study Sites (1)

Manisa Celal Bayar University

Manisa, Turkey (Türkiye)

RECRUITING

MeSH Terms

Interventions

Muscle Stretching Exercises

Intervention Hierarchy (Ancestors)

Exercise Therapy; Rehabilitation; Aftercare; Continuity of Patient Care; Patient Care; Therapeutics; Physical Therapy Modalities; Exercise; Motor Activity; Movement; Musculoskeletal Physiological Phenomena; Musculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Erhan Secer, PhD

CONTACT

+905557355018; erhnscr86@hotmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Masking Details: The intervention group will receive proprioceptive neuromuscular facilitation and outcome measures will be assessed by an investigator who was blinded to the group allocation.
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Lecturer, PT., PhD.

Model Details: This study will be conducted as a randomized controlled trial. Participants will be randomly assigned to two groups: the intervention group (proprioceptive neuromuscular facilitation intervention) and the control group (no intervention).

Study Record Dates

• First Submitted: January 7, 2026
• First Posted: January 15, 2026
• Study Start: February 1, 2026
• Primary Completion: March 8, 2026
• Study Completion: March 15, 2026
• Last Updated: March 13, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)